Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
NCT00317109
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL:
Tritanrix™- HepB
BIOLOGICAL:
Hiberix™
BIOLOGICAL:
Mencevax™ ACW
Sponsor
GlaxoSmithKline